Abbott Laboratories (ABL) Q2 2022 Earnings Report
DE:ABL Q2 2022 EPS Results
- Actual EPS
- EUR 1.27
- Consensus EPS
- EUR 1.00
- Beat/Miss
- Beat by +EUR 0.27
- One Year Ago EPS
- EUR 1.04
DE:ABL Q2 2022 Revenue Results
- Actual Revenue
- EUR 10.03B
- Expected Revenue
- EUR 9.20B
- Beat/Miss
- Beat by +EUR 830.31M
- YoY Revenue Growth
- +10.11%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 07/20/2022
- Time
- Before Open
- Conference Call
- Wednesday, July 20, 2022
DE:ABL Upcoming Earnings
Abbott Laboratories's next earnings date is estimated for January 27, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:ABL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 27, 2027 | 2026 (Q4) | 1.46- | 1.34 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 1.271.27 | 1.16 | 9.23% (+0.11) | |
| Jul 16, 2026 | 2026 (Q2) | 1.141.17 | 1.12 | 3.97% (+0.04) | |
| Apr 16, 2026 | 2026 (Q1) | 1.021.02 | 0.97 | 5.50% (+0.05) | |
| Jan 22, 2026 | 2025 (Q4) | 1.331.34 | 1.19 | 11.94% (+0.14) | |
| Oct 15, 2025 | 2025 (Q3) | 1.161.16 | 1.08 | 7.44% (+0.08) | |
| Jul 17, 2025 | 2025 (Q2) | 1.121.12 | 1.02 | 10.53% (+0.11) | |
| Apr 16, 2025 | 2025 (Q1) | 0.960.97 | 0.87 | 11.22% (+0.10) | |
| Jan 22, 2025 | 2024 (Q4) | 1.201.19 | 1.06 | 12.61% (+0.13) | |
| Oct 16, 2024 | 2024 (Q3) | 1.071.08 | 1.02 | 6.14% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed